ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer (DEVELOP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01714765
Recruitment Status : Completed
First Posted : October 26, 2012
Last Update Posted : November 13, 2013
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Centre of Experimental Medicine, Queen Mary University of London

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2012
  Actual Study Completion Date : October 2012